Sectors & IndustriesConsumer DefensivePharmaceutical Retailers

Best Pharmaceutical Retailer Stocks to Buy Now (2023)

Top pharmaceutical retailer stocks in 2023 ranked by overall Zen Score. See the best pharmaceutical retailer stocks to buy now, according to analyst forecasts for the pharmaceutical retailers industry.

According to Zen Score, the 3 best drug store stocks to buy right now are:

Leafly Holdings (NASDAQ:LFLY) is the top pharmaceutical retailer stock with a Zen Score of 50, which is 23 points higher than the pharmaceutical retailer industry average of 27. It passed 16 out of 33 due diligence checks and has strong fundamentals. Leafly Holdings has seen its stock lose -91.61% over the past year, underperforming other pharmaceutical retailer stocks by -44 percentage points.

Leafly Holdings has an average 1 year price target of $4.00, an upside of 566.67% from Leafly Holdings's current stock price of $0.60.

Leafly Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Leafly Holdings, 0% have issued a Strong Buy rating, 50% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Petmed Express (NASDAQ:PETS) is the second best pharmaceutical retailer stock with a Zen Score of 42, which is 15 points higher than the pharmaceutical retailer industry average of 27. It passed 14 out of 38 due diligence checks and has strong fundamentals. Petmed Express has seen its stock lose -16% over the past year, overperforming other pharmaceutical retailer stocks by 31 percentage points.

Petmed Express has an average 1 year price target of $18.00, a downside of -16.36% from Petmed Express's current stock price of $21.52.

Petmed Express stock has a consensus Strong Sell recommendation according to Wall Street analysts. Of the 1 analyst covering Petmed Express, 0% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 100% have issued a Strong Sell.

Greenlane Holdings (NASDAQ:GNLN) is the third best pharmaceutical retailer stock with a Zen Score of 38, which is 11 points higher than the pharmaceutical retailer industry average of 27. It passed 12 out of 33 due diligence checks and has average fundamentals. Greenlane Holdings has seen its stock lose -96.69% over the past year, underperforming other pharmaceutical retailer stocks by -49 percentage points.

Greenlane Holdings has an average 1 year price target of $1.38, an upside of 216.09% from Greenlane Holdings's current stock price of $0.44.

Greenlane Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Greenlane Holdings, 0% have issued a Strong Buy rating, 50% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 2 pharmaceutical retailer stocks that have issued dividends in the past year, the 2 pharmaceutical retailer stocks with the highest dividend yields are:

Petmed Express (NASDAQ:PETS) has an annual dividend yield of 5.58%, which is the same as the pharmaceutical retailer industry average of 5.36%. Petmed Express's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Petmed Express's dividend has shown consistent growth over the last 10 years.

Petmed Express's dividend payout ratio of 115.4% indicates that its high dividend yield might not be sustainable for the long-term.

Walgreens Boots Alliance (NASDAQ:WBA) has an annual dividend yield of 5.15%, which is the same as the pharmaceutical retailer industry average of 5.36%. Walgreens Boots Alliance's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Walgreens Boots Alliance's dividend has shown consistent growth over the last 10 years.

Walgreens Boots Alliance's dividend payout ratio of -55.7% indicates that its high dividend yield might not be sustainable for the long-term.

Pharmaceutical retailer stocks were up 1.67% in the last day, and up 7.08% over the last week.

We couldn't find a catalyst for why pharmaceutical retailer stocks are up.

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical retailer stocks right now are:

Leafly Holdings (NASDAQ:LFLY) is the most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Leafly Holdings has a valuation score of 86, which is 54 points higher than the pharmaceutical retailer industry average of 32. It passed 6 out of 7 valuation due diligence checks.

Leafly Holdings's stock has dropped -91.61% in the past year. It has underperformed other stocks in the pharmaceutical retailer industry by -44 percentage points.

Greenlane Holdings (NASDAQ:GNLN) is the second most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Greenlane Holdings has a valuation score of 43, which is 11 points higher than the pharmaceutical retailer industry average of 32. It passed 3 out of 7 valuation due diligence checks.

Greenlane Holdings's stock has dropped -96.69% in the past year. It has underperformed other stocks in the pharmaceutical retailer industry by -49 percentage points.

Bimi International Medical (NASDAQ:BIMI) is the third most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Bimi International Medical has a valuation score of 43, which is 11 points higher than the pharmaceutical retailer industry average of 32. It passed 3 out of 7 valuation due diligence checks.

Bimi International Medical's stock has dropped -92.42% in the past year. It has underperformed other stocks in the pharmaceutical retailer industry by -45 percentage points.